Page last updated: 2024-09-03

2-chloro-n(6)cyclopentyladenosine and veratridine

2-chloro-n(6)cyclopentyladenosine has been researched along with veratridine in 1 studies

Compound Research Comparison

Studies
(2-chloro-n(6)cyclopentyladenosine)
Trials
(2-chloro-n(6)cyclopentyladenosine)
Recent Studies (post-2010)
(2-chloro-n(6)cyclopentyladenosine)
Studies
(veratridine)
Trials
(veratridine)
Recent Studies (post-2010) (veratridine)
2520431,755086

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amoroso, S; Annunziato, L; Di Renzo, G; Iannotti, E; Saggese, ML1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and veratridine

ArticleYear
The A1 agonist CCPA reduced bisoxonol-monitored membrane potential depolarization elicited by high K+ in cerebrocortical nerve endings.
    Biochimica et biophysica acta, 1995, Oct-04, Volume: 1239, Issue:1

    Topics: Adenosine; Animals; Cerebral Cortex; Fluorescent Dyes; Male; Membrane Potentials; Nerve Endings; Phenethylamines; Potassium; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Rats; Rats, Wistar; Synaptosomes; Thiobarbiturates; Triazoles; Veratridine; Xanthines

1995